BioPharma has experienced significant growth in recent years. This report by Robert Stoner and Jéssica Dutra, prepared for Pfizer, on the BioPharma Economic Impact in the US Economy demonstrates that the BioPharma industry in the United States provides significant value added to the GDP, a significant “multiplier” effect on employment and earnings, and a major R&D presence in the United States and worldwide.